Zealand Pharma
Clinical trials sponsored by Zealand Pharma, explained in plain language.
A biopharmaceutical company focused on peptide-based medicines for metabolic and gastrointestinal diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New drug aims to control blood sugar in kids with rare condition
Disease control CompletedThis study is testing the long-term safety of dasiglucagon, a drug given as a continuous injection under the skin, in children with congenital hyperinsulinism (a condition causing dangerously low blood sugar). The trial includes 42 children who completed earlier studies. Research…
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Weekly shot shows promise for shedding pounds in obesity trial
Disease control CompletedThis study tested a new weekly injection called petrelintide to help people with obesity or overweight (plus related health issues) lose weight. About 493 participants received either the drug or a placebo, along with diet and exercise advice, for 28 weeks. The main goal was to s…
Phase: PHASE2 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Weight-Loss drug candidate put through its paces in early dosing study
Knowledge-focused CompletedThis early-stage study tested a single injection of petrelintide, a potential weight-management drug, in 48 adults with a BMI of 27 or higher. Researchers wanted to see if using different concentrations of the drug changed how the body processes it or affected safety. Participant…
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Kidney function may affect new Weight-Loss drug
Knowledge-focused CompletedThis study tested a new weight-management drug called petrelintide in 39 people with normal or impaired kidney function. Researchers wanted to see if kidney problems change how the drug behaves in the body. The goal is to guide safe dosing for people with kidney issues who might …
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC